Alkylating Agents prototype
Chlorambucil
Chlorambucil indications
Palliative treatment of chronic lymphocytic leukemia, malignant lymphomas, and Hodgkin disease.
Chlorambucil actions
Alkylates cellular DNA, interfering with the replication of susceptible cells.
Chlorambucil route, onset, peak, duration
Oral, varies, 1 h, 15-20 h
Chlorambucil adverse effects
Tremors, muscle twitching, confusion, nausea, hepatotoxicity, bone marrow suppression, sterility, cancer.